A detailed history of Oppenheimer Asset Management Inc. transactions in Conmed Corp stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 34,864 shares of CNMD stock, worth $2.52 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
34,864
Previous 35,040 0.5%
Holding current value
$2.52 Million
Previous $2.43 Million 3.25%
% of portfolio
0.03%
Previous 0.03%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$64.09 - $76.92 $11,279 - $13,537
-176 Reduced 0.5%
34,864 $2.51 Million
Q2 2024

Aug 08, 2024

BUY
$61.9 - $80.36 $448,094 - $581,726
7,239 Added 26.04%
35,040 $2.43 Million
Q1 2024

May 06, 2024

SELL
$75.36 - $112.51 $358,939 - $535,885
-4,763 Reduced 14.63%
27,801 $2.23 Million
Q4 2023

Feb 13, 2024

SELL
$91.3 - $115.05 $74,500 - $93,880
-816 Reduced 2.44%
32,564 $3.57 Million
Q3 2023

Nov 07, 2023

SELL
$97.55 - $135.91 $23,899 - $33,297
-245 Reduced 0.73%
33,380 $3.37 Million
Q2 2023

Aug 02, 2023

SELL
$102.55 - $136.38 $280,166 - $372,590
-2,732 Reduced 7.51%
33,625 $4.57 Million
Q1 2023

May 10, 2023

BUY
$89.75 - $107.27 $390,233 - $466,409
4,348 Added 13.58%
36,357 $3.78 Million
Q4 2022

Feb 06, 2023

SELL
$72.84 - $94.04 $60,675 - $78,335
-833 Reduced 2.54%
32,009 $2.84 Million
Q3 2022

Nov 14, 2022

BUY
$77.78 - $103.92 $60,746 - $81,161
781 Added 2.44%
32,842 $2.63 Million
Q2 2022

Aug 08, 2022

SELL
$88.23 - $154.18 $96,347 - $168,364
-1,092 Reduced 3.29%
32,061 $3.07 Million
Q1 2022

May 12, 2022

SELL
$121.88 - $150.0 $52,652 - $64,800
-432 Reduced 1.29%
33,153 $4.92 Million
Q4 2021

Feb 02, 2022

BUY
$129.86 - $157.03 $244,006 - $295,059
1,879 Added 5.93%
33,585 $4.76 Million
Q3 2021

Nov 12, 2021

BUY
$122.87 - $139.12 $10,935 - $12,381
89 Added 0.28%
31,706 $4.15 Million
Q2 2021

Aug 03, 2021

BUY
$128.08 - $145.09 $168,297 - $190,648
1,314 Added 4.34%
31,617 $4.35 Million
Q1 2021

May 17, 2021

BUY
$111.35 - $130.59 $327,925 - $384,587
2,945 Added 10.76%
30,303 $3.96 Million
Q4 2020

Feb 11, 2021

BUY
$77.7 - $112.82 $349,805 - $507,915
4,502 Added 19.7%
27,358 $3.06 Million
Q3 2020

Nov 13, 2020

BUY
$69.87 - $89.2 $1.6 Million - $2.04 Million
22,856 New
22,856 $1.8 Million
Q1 2020

May 08, 2020

SELL
$39.81 - $112.01 $3,224 - $9,072
-81 Closed
0 $0
Q3 2019

Oct 31, 2019

BUY
$83.97 - $102.19 $1,343 - $1,635
16 Added 24.62%
81 $8,000
Q2 2019

Aug 09, 2019

BUY
$78.27 - $86.94 $5,087 - $5,651
65 New
65 $6,000
Q3 2018

Oct 26, 2018

SELL
$73.09 - $81.64 $224,167 - $250,389
-3,067 Closed
0 $0
Q2 2018

Aug 10, 2018

SELL
$61.34 - $76.43 $130,715 - $162,872
-2,131 Reduced 41.0%
3,067 $225,000
Q1 2018

May 09, 2018

BUY
$50.61 - $64.53 $36,034 - $45,945
712 Added 15.87%
5,198 $329,000
Q3 2017

Nov 14, 2017

BUY
$48.38 - $52.52 $217,032 - $235,604
4,486
4,486 $235,000

Others Institutions Holding CNMD

About CONMED Corp


  • Ticker CNMD
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 30,482,400
  • Market Cap $2.2B
  • Description
  • CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide uni...
More about CNMD
Track This Portfolio

Track Oppenheimer Asset Management Inc. Portfolio

Follow Oppenheimer Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.